1. Wang, Zhiwei, Li, Mingxing, Liu, Yuanfeng, Liu, Bo, Bai, Tao. 2022. CRHBP is degraded via autophagy and exerts anti-hepatocellular carcinoma effects by reducing cyclin B2 expression and dissociating cyclin B2-CDK1 complex. In Cancer gene therapy, 29, 1217-1227. doi:10.1038/s41417-021-00423-4. https://pubmed.ncbi.nlm.nih.gov/35082401/
2. Linnstaedt, Sarah D, Bortsov, Andrey V, Soward, April C, Hendry, Phyllis L, McLean, Samuel A. . CRHBP polymorphisms predict chronic pain development following motor vehicle collision. In Pain, 157, 273-279. doi:10.1097/j.pain.0000000000000374. https://pubmed.ncbi.nlm.nih.gov/26447706/
3. Xia, Hai-Bing, Wang, Hui-Ju, Fu, Luo-Qin, Mou, Xiao-Zhou, Huang, Dong-Sheng. 2018. Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma. In Oncology letters, 16, 3681-3689. doi:10.3892/ol.2018.9073. https://pubmed.ncbi.nlm.nih.gov/30127978/
4. Chen, Bangjie, Chen, Sanwei, Wang, Xinyi, Yu, Feng, Kong, Weihao. 2024. A pan-cancer analysis uncovering the function of CRHBP in tumor immunity, prognosis and drug response: especially its function in LIHC. In Scientific reports, 14, 3112. doi:10.1038/s41598-024-52387-8. https://pubmed.ncbi.nlm.nih.gov/38326407/
5. Kashiwagi, Mitsuaki, Beck, Goichi, Kanuka, Mika, Mochizuki, Hideki, Hayashi, Yu. 2024. A pontine-medullary loop crucial for REM sleep and its deficit in Parkinson's disease. In Cell, 187, 6272-6289.e21. doi:10.1016/j.cell.2024.08.046. https://pubmed.ncbi.nlm.nih.gov/39303715/
智鼠故事 
